.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
McKesson
Farmers Insurance
UBS
Fuji
Moodys
Merck
Fish and Richardson
AstraZeneca
Medtronic

Generated: July 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201333

« Back to Dashboard
NDA 201333 describes FAMCICLOVIR, which is a drug marketed by Aurobindo Pharma Ltd, Macleods Pharms Ltd, West-ward Pharms Int, Mylan, Hetero Labs Ltd V, Cipla Ltd, Apotex, and Teva Pharms, and is included in eight NDAs. It is available from eighteen suppliers. Additional details are available on the FAMCICLOVIR profile page.

The generic ingredient in FAMCICLOVIR is famciclovir. There are eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the famciclovir profile page.

Summary for NDA: 201333

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Pharmacology for NDA: 201333

Ingredient-typeNucleoside Analog
Mechanism of ActionDNA Polymerase Inhibitors

Suppliers and Packaging for NDA: 201333

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FAMCICLOVIR
famciclovir
TABLET;ORAL 201333 ANDA Mylan Pharmaceuticals Inc. 0378-4490 0378-4490-93 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4490-93)
FAMCICLOVIR
famciclovir
TABLET;ORAL 201333 ANDA Mylan Pharmaceuticals Inc. 0378-4491 0378-4491-93 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-4491-93)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength125MG
Approval Date:Mar 24, 2011TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Mar 24, 2011TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Mar 24, 2011TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Fuji
Farmers Insurance
Mallinckrodt
Colorcon
Healthtrust
Cerilliant
Medtronic
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot